Showing results (141-150 of 191) with videos related to
Sort By:
Pageof 20
Plos One|September 17, 2013
Predictability of persistent frequent attendance in primary care: a temporal and geographical validation studyFrans T Smits, Henk J Brouwer, Aeilko H Zwinderman, et al.Journal of Autism and Developmental Disorders|January 25, 2021
Is a Negative Attentional Bias in Individuals with Autism Spectrum Disorder Explained by Comorbid Depression? An Eye-Tracking StudyM Annemiek Bergman, Janna N Vrijsen, Mike Rinck, et al.Brain : a Journal of Neurology|July 8, 2019
Impaired reward-related learning signals in remitted unmedicated patients with recurrent depressionHanneke Geugies, Roel J T Mocking, Caroline A Figueroa, et al.Human Brain Mapping|March 14, 2019
Altered ability to access a clinically relevant control network in patients remitted from major depressive disorderCaroline A Figueroa, Joana Cabral, Roel J T Mocking, et al.Frontiers in Psychiatry|April 16, 2019
Emotional Biases and Recurrence in Major Depressive Disorder. Results of 2.5 Years Follow-Up of Drug-Free Cohort Vulnerable for RecurrenceHenricus G Ruhe, Roel J T Mocking, Caroline A Figueroa, et al.Biological Psychiatry|December 22, 2005
Glucocorticoids and relapse of major depression (dexamethasone/corticotropin-releasing hormone test in relation to relapse of major depression)Bente C Appelhof, Jochanan Huyser, Mijke Verweij, et al.Frontiers in Psychiatry|August 9, 2022
Neural correlates of repetitive negative thinking: Dimensional evidence across the psychopathological continuumJasper van Oort, Indira Tendolkar, Rose Collard, et al.Journal of Clinical Medicine|August 27, 2021
Beneficial Effects of Opioid Rotation to Buprenorphine/Naloxone on Opioid Misuse, Craving, Mental Health, and Pain Control in Chronic Non-Cancer Pain Patients with Opioid Use DisorderArnt F A Schellekens, Stijn E Veldman, Eka S D Suranto, et al.The Journal of Clinical Endocrinology and Metabolism|September 8, 2005
Polymorphisms in type 2 deiodinase are not associated with well-being, neurocognitive functioning, and preference for combined thyroxine/3,5,3'-triiodothyronine therapyBente C Appelhof, Robin P Peeters, Wilmar M Wiersinga, et al.Journal of Affective Disorders|May 1, 2022
Negative cognitive schema modification as mediator of symptom improvement after electroconvulsive therapy in major depressive disorderDominique S Scheepens, Jeroen A van Waarde, Freek Ten Doesschate, et al.Pageof 20